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Abstract  
BACKGROUND: Antibiotics are among the most commonly prescribed drugs in paediatrics. In most cases, 
antibiotics are started on an empirical basis, without proof of a bacterial infection, either before the start of therapy 
or afterwards. 
 
AIM: The main objective of this study was to analyse the consumption of antibiotics in hospitalised paediatric 
patients.
 
MATERIAL AND METHODS: This retrospective study investigated the consumption of antimicrobials in defined 
daily doses (DDDs according to the Anatomical Therapeutical Chemical/DDD index) in Pulmonology, 
Gastroenterology and Nephrology Departments at Pediatric Clinic of the tertiary hospital. The data on the 
consumption of antimicrobials were collected for five years by using properly designed form. The consumption 
was related to days of hospital care.
 
RESULTS: The most utilised antibiotics group in all three departments Pulmonology, Gastroenterology and 
Nephrology Departments were penicillins. Cephalosporins were mostly used in Pulmonology department. 
Metronidazole and Chloramphenicol were used in minimal quantities in all three departments.
 
CONCLUSION: This study demonstrates that surveillance programs on antibiotic resistance should be 
established and accompanied by analyses of drug utilisation data which can aid in the creation of valid cross-
national studies on antibiotic usage and resistance, to motivate improvements in prescribing and guideline-
directed antibiotic prescribing.  
 
 
 
Introduction 
 
Drug therapy is considered to be a major 
component of paediatric management in health care 
settings like hospitals. Effective medical treatment of a 
paediatric patient is based upon an accurate 
diagnosis and optimum course of therapy, which 
usually involves a medication regimen.
 
Antibiotics are the most commonly prescribed 
drugs in children with the highest incidence rates in 
preschoolers [1].  
Investigating and monitoring the consumption 
of antimicrobials in hospitals is necessary to 
encourage prudent use of these drugs. The use of 
broad spectrum antibacterials is a potential problem. 
The issue of antibiotic resistance is of global concern 
and considered a threat to modern health care, 
rendering patients at risk of ineffective treatment 
regimens and societies strained by increasing health 
care costs. Antibiotic consumption is directly related to 
the antibiotic resistance rates of common bacteria [2]. 
In European countries, antibiotics are mainly 
used in primary care. However, hospitals are 
considered to be the centre of antimicrobial resistance 
owing to the higher use of broad-spectrum agents in 
both adults and children [3]. 
Numerous studies have investigated the 
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consumption of antimicrobials in hospitalised adult 
patients by using DDDs, but such studies in paediatric 
patients are in large scale missing [3–6]. 
The determination of criteria for rational 
antimicrobial therapy is derived from the definition for 
rational therapy: ordination of antibiotics drug in 
optimal dose, in safe mode and optimal duration. 

 
The Center for Disease Control and 
Prevention (CDC) 12-step program to prevent 
antimicrobial resistance was launched in 2000 to 
educate clinicians about antimicrobial resistance and 
provide strategies to improve clinical practice. 
However, the drug prescription in our centre depends 
on drug availability in Central Pharmacy while the 
drug supply is depended on donations. On the other 
hand, there is no official drug policy or protocol of 
treatments, so the doctors are not obligated to follow 
any official antibiotic protocols.
 
Detailed knowledge of actual prescribing 
patterns is necessary to plan relevant activities that 
limit excessive use of antibiotics in general as well as 
of particular types of antibiotics. 
The aim of this study was the analysis of 
antibiotic consumption structure used to treat the 
respiratory, urinary and gastrointestinal infections in 
children in Pediatric Clinic of University Clinical Center 
of Kosovo (UCKK).  
 
 
Material and Methods 
 
Pediatric Clinic, University of Prishtina, is a 
tertiary hospital in Kosovo. It has active units of 
Pulmonology, Nephrology and Gastroenterology 
Departments. 
 
All data were collected retrospectively by the 
clinical pharmacologist from the inpatient medication 
charts and the patient’s medical notes of 143 
hospitalised patients for five years. Properly designed 
form sheet was used for data collection.
 
Our retrospective study investigated the 
consumption of antimicrobials in daily defined dose 
(DDD) per 1000 bed days (BD) [7].
 
Because the study 
was held in paediatric settings, the modified 
DDD/1000 – BD was used. The modified DDD/100 – 
BD for children is presented in age-group categories. 
The appropriateness of DDD by age-group is 
determined as a conclusion of WHO [2]. 
The antimicrobials included in this study were 
the following (according to Anatomical Therapeutic 
Chemical/Daily Defined Doses–ATC/DDD 
classification system defined by WHO 2010): 
J anti-infectives for systemic use: 
 J01 antibacterials: J01A tetracyclines, J01B 
amphenicols, J01C beta-lactam antibacterials, 
penicillins, J01D other beta-lactam 
antibacterials, J01E sulfonamides and 
trimethoprim, J01F macrolides, lincosamides 
and streptogramins, J01G aminoglycoside 
antibacterials, J01M quinolone antibacterials, 
J01R combinations of antibacterials, J01X 
other antibacterials. 
 J02 antifungals: J02AA antibiotics, J02AC 
triazoles, J02AX other systemic antifungals. 
 J05 antivirals: J05AB nucleosides and 
nucleotides excluding reverse transcriptase 
inhibitors, J05AD phosphonic acid derivatives, 
J05AE protease inhibitors, J05AF nucleoside 
and nucleotide reverse transcriptase 
inhibitors, J05AG non-nucleoside reverse 
transcriptase inhibitors, J05AH neuraminidase 
inhibitors, J05AR antivirals for treatment of 
HIV infections. 
 
 
Results 
 
The total consumption of antibiotics in 
Pulmonology Department (PD) was 472.82 DDD/1000 
B.D, while in Gastroenterology Department (GD) was 
121.95 DDD/1000 B.D and in Nephrology Department 
(DN), 294.22 DDD/1000 B.D.  
The most utilised antibiotics group in 
Pulmonology Department were penicillins (271.22 
DDD/1000 - BD or 57.36%. of total consumption), 
cephalosporins (98.46 DDD/1000-BD or 20.82%) than 
macrolides (72.70 DDD/1000-BD or 6.27%).  
In Gastroenterology Department the most 
utilized groups were penicillin (53.63 DDD/1000 - BD 
or 43.98 % and amino glycosides (40.18 DDD/1000 - 
BD or 32.95 % of total consumption), while in ND the 
most utilized antibiotics, were penicillin (179.11 
DDD/1000 – BD or 60.88 %) and cephalosporin 
(51.87 DDD/1000 – BD or 17.63%)  
Metronidazole and Chloramphenicol were 
used in minimal quantities in all three departments 
(Tale 1). 
Table 1: Structure of antibiotics expenditure (J group by ATC 
classification) 
ATC Drug Group 
Pulmonology 
Department
 
Gastroenterology 
Department 
Nephrology 
Department 
DDD/ 
1000- 
BD 
% 
DDD/ 
1000 – 
BD 
% 
DDD/ 
1000 – 
BD 
% 
J01 J01BA01 Chloramphenicol 0.0041 0.0008 0.658436 0.54 0.92 0.31 
 J01C Penicillin 271.23 57.36 53.63 43.98 179.11 60.88 
 J01DA Cephalosporin 98.46 20.82 18.92 15.51 51.87 17.63 
 J01FA Macro lids 72.70 15.38 6.48 5.31 9.26 3..15 
 J01G 
Amino 
glycosides 
29.65 6.27 40.18 32.95 14.43 4.90 
 J01XD01 Metronidazole
 0.77 0.16 2.08 1.71 3.55 1.21 
J04  
Antituberculosis

 
0.00 0.00 0.00 0.00 35.08 11.92 
Total 472.82 100.00 121.95 100.00 259.14 100.00 
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Three departments used drug combination of 
Trimethoprim and Sulfamethoxazole (Table 2). 
Trimethoprim - sulfamethoxazole was most 
utilised in Nephrology Department (75.926 ED/1000-
BD), than in Gastroenterology Department (67.67 
ED/1000-BD), while less utilised was in Pulmonology 
Department (Table 2). 
Table 2: Expenditure on combine anti-infective drugs by 
departments
 
ATC Drug  
Pulmonolo
gy 
Departmen
t   
Gastroenterolo
gy Department   
Nephrology 
Department 
ED/ 
1000- BD 
ED/ 
1000 - BD 
ED/ 
1000 - BD 
J01 J01E J01EE J01EE01 
Trimethoprim+ 
Sulfamethoxazole 
 
45.062 67.670 75.926 
 
In Pulmonology Department the most utilised 
antibiotics are Procaine penicillin (23.10% of total 
consumption), than Erythromycin (13.88%), 
Amoxicillin (13.02%) and Benzyl penicillin (10.53%). 
The expenditure of cephalosporin took in the second 
place, and most utilised antibiotics from this group 
were: Ceftriaxone (4.11%), and Cefuroxime (2.21%).  
In Gastroenterology Department most utilised, 
antimicrobics were: Procaine-Penicillin (34.17%), than 
Gentamycin (23,46%), Ceftriaxone (9.82%), 
Amoxicillin-clavulanic acid (6.20%) and Erythromycin 
(5.31%). 
 
In Nephrology Department most utilised 
antibiotics were: Procaine Penicillin (29.37%), 
Amoxicillin-clavulanic acid (15.87%), Amoxicillin 
(10.70%), Cefuroxime (6.29%) and Cefaclor (5.85%). 
In Department of Nephrology the antituberculosis are 
utilised in smaller quantities (Rifampicin 3.25%, 
Isoniazid and Pyrazinamide with 4.34 %) (Table 1). 
In all three departments, 25 antibiotics from 
drug group J are used (Table 3). 
Table 3: The structure of systemic anti-infective (J group) by 
subgroup of ATC classification 
ATC Drugs 
Pulmonology 
Department  
 
Gastroenterology 
Department   
Nephrology 
Department 
DDD/ 
1000- 
BD 
% 
DDD/ 
1000 - 
BD 
% 
DDD/ 
1000 - 
BD 
% 
J01 J01B J01BA J01BA01 Chloramphenicol 0.004 0.0008 0.66 0.54 0.92 0.31 
 J01C J01CA J01CA01 Ampicillin 7.04 1,49 2.01 1.65 12.65 4.30 
   J01CA04 Amoxicillin 61.57 13.02 0.46 0.38 31.48 10.70 
  J01CE J01CE01 Benzylpenicillin  49.79 10.53 0.00 0.00 0.00 0.00 
   J01CE08 
Benzathine-
benzylpenicillin 
0.00 0.00 0.00 0.00 1.85 0.63 
   J01CE30 
Procaine-
Penicillin 
109.26 23..10 41.67 34.17 86.42 29.37 
  J01CF J01CF02 Cloxacillin Na 24.35 5.15 1.93 1.58 0.00 0.00 
  J01CR J01CR02 
Amoxicillin–
clavulanic 
acid 
 
19.22 4.064 7.56 6.20 46.70 15.87 
 J01D J01DA J01DA01 Cephalexin 3.78 0.80 0.00 0.00 0.00 0.00 
   J01DA04 Cephazolin 5.76 1.22 0.00 0.00 0.00 0.00 
   J01DA05 Cefoxitin 0.00 0.00 0.00 0.00 1.54 0.52 
   J01DA06 Cefuroxime 24.69 5.22 3.70 3.04 18.52 6.29 
   J01DA08 Cefaclor 7.96 1.68 3.24 2.66 17.22 5.85 
   J01DA11 Ceftazidime 10.41 2.20 0.00 0.00 1.62 0.55 
   J01DA13 Ceftriaxone 45.86 9.70 11.98 9.82 12.96 4.41 
 J01F J01FA J01FA01 Erythromycine 65.62 13.88 6.48 5.31 9.26 3.15 
   J01FA10 Azithromycine 7.08 1.49 0.00 0.00 0.00 0.00 
 J01G J01GA J01GA01 Streptomycin   1.48 1.21 0.00 0.00 
  J01GB J01GB03 Gentamycin 25.32 5.35 28.61 23.46 10.08 3.43 
   J01GB06 Amikacin 4.33 0.91 10.09 8.27 4.35 1.48 
 J01X J01XD J01XD01 Metronidazol 0.77 0.16 2.08 1.71 3.55 1.21 
J04 J04A J04AB J04AB02 Rifampicin 0.00 0.00 0.00 0.00 9.57 3.25 
  J04AC J04AC01 Isoniazid 0.00 0.00 0.00 0.00 12.76 4.34 
   J04AK01 Pyrazinamide 0.00 0.00 0.00 0.00 12.76 4.34 
           
Total 472.82 100.00 121.95 100.00 294.22 100.00 
Discussion 
 
Antibiotic resistance is an emerging public 
health issue of major concern worldwide which has 
been associated with antibiotic consumption.  
To our knowledge, few studies on antibiotic 
prescribing in paediatric patients have been 
performed until now, especially in developing 
countries like Kosovo [5, 8, 9].  
The drug utilisation research enables the 
identification of eventual problems and application of 
right measurement with an aim for rational and 
modern treatment therapy. 
 
In our study, we demonstrated a relatively 
stable high overall incidence rate of antibiotic use in 
paediatric patients. The utilisation of antibiotics is 
different in three departments, due to different 
pathologies which have been treated in those 
departments. 
 
The criteria for diagnosis in Departments of 
Pulmonology, Gastroenterology and Nephrology, were 
history taking, clinical examination, biochemistry, 
haematology, bacteriologic analyses, pulmonary 
radiological examination and ultrasound examination 
of the gastrointestinal tract and urinary tract.  
The results of drug expenditure from our 
research are classified as rational expenditure 
comparing with drug expenditure in other countries in 
transitional phase [8–10]. 
Krasniqi et al. in one similar survey presented 
that in Orthopedic Clinic of UCCK, the total 
consumption of antimicrobials in 2001 were 79.36 
DDDs100 bed days within a small decline in total 
consumption of antimicrobials of 3.5% in 2006 (76.86 
DDDs/100 bed days). In two time periods, the most 
utilised drug groups were: other ß-lactam antibiotics, 
aminoglycosides and ß-lactam antibiotic-penicillin's. 
This finding shows the higher consumption of 
antibiotic in the Clinic of Orthopedics compared to our 
study at the Clinic of Pediatrics [16]. 
 
Expenditure of penicillin in Department of 
Nephrology is a sign of rational treatment because 
penicillin is first line treatment of β-hemolytic 
streptococci renal infections.
 
Palcevski et al. [9] presented that the total 
consumption of antibiotic in Rijeka, Croatia was three 
times more than in Smolensk, Russia (28.96 vs. 8.3 
DD/100 - BD). In Rijeka were administered 35 
different antibiotics (the most utilised were: 
cefuroxime), while in Smolensk 22 antimicrobials (the 
most utilised amoxicillin).
 
In Department of Nephrology, in our centre, 
expenditure was 1.4 times more than in the University 
of Rijeka.
 
In Department of Pulmonology of Pediatric 
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Clinic, the most utilised antibiotic was Procaine 
penicillin. Sestina et al. [10] showed that in 
hospitalised paediatric patients in Birmingham the 
most frequently used antibiotic was co-amoxiclav 
while in Riga ampicillin and amoxicillin were most 
commonly used. This difference in practice is 
interesting as in most cases these narrow-spectrum 
agents provide sufficient cover for the majority of 
pathogens associated with community acquired 
pneumonia. 
 
Vaz et al. [11] also showed that the majority of 
antibiotics dispensed for respiratory tract infections for 
children included penicillins, cephalosporins, and 
second-generation macrolides. 
The high non-rational expenditure of some 
antibiotics, especially penicillins in Department of 
Gastroenterology, create conditions for destroying of 
bowel normal bacterial flora and domination of 
pathogen bacteria with the possibility of development 
of bacterial resistance. To decrease costs, as well as 
to reduce the possibility of increasing antimicrobial 
resistance among circulating strains, clinicians should 
choose the narrowest antibiotic regimen that 
adequately covers the predicted organisms for each 
case.
 
Several studies have investigated the role of 
probiotics for the prevention of community- and 
nosocomial-acquired diarrhoea, antibiotic-associated 
diarrhoea and travellers' diarrhoea [12, 13], but a 
discussion on those topics goes beyond the scope of 
this article. 
The high use of cephalosporins in our centre 
is similar to findings in other studies where 
cephalosporins in general (and ceftriaxone in 
particular) were among the most frequently used 
antibiotics [8–10]. Non-restricted use of third-
generation cephalosporins could lead to an increase 
in resistant Escherichia coli and Klebsiella pneumonia. 
The clinical manifestation of any infection, 
initially justify the antibiotics administration, but after 
48-72 hours in a case, that microbiological analyses 
shows negative results is necessary to stop the 
antibiotics administration. 
 
Because of the shortage in the budget, in 
public hospitals in Kosovo, the antibiotic supply also 
depends on donations, so there are no national 
recommendations promoting good antimicrobial 
stewardship. Actions to promote the prudent use of 
antibiotics remain with the individual hospitals. 
 
Although some data suggest that restrictive 
methods (formulary restrictions with policing by clinical 
pharmacists) are more effective than educational 
interventions, there is a need for both [3, 14, 15]. 
Although the DDD method has also been 
used in paediatric studies, the lack of standardised 
international paediatric DDD could be considered as a 
limitation of the study. Nevertheless, to overcome this, 
we used the modified DDD/1000 – BD for children.
 
In conclusion, the antibiotic use in three 
departments of Clinic of Pediatrics is high compared 
to other European Countries. In three departments, 
the penicillin's are a most utilised antibiotic subgroup 
and this show rationality according to the structure of 
used antimicrobials. The total consumption of 
antibiotics significantly differs in three departments of 
Pediatric Clinic. The consumption of cefalosporins and 
aminoglycosides is relatively high, and this main 
concern is reflecting the non-rationality of antibiotic 
prescription due to the impact of cephalosporins in the 
development of bacterial resistance and problematic 
safety profile of aminoglycosides especially in 
children.  
This study demonstrates that surveillance 
programs on antibiotic resistance should be 
established and accompanied by analyses of drug 
utilisation data which can aid in the creation of valid 
cross-national studies on antibiotic usage and 
resistance, to motivate improvements in prescribing 
and guideline-directed antibiotic prescribing. 
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